General Information of Drug Formulation (ID: F10583)

Formulation Name
Indinavir 200 mg capsule
Company
Merck Sharp & Dohme
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Beta-D-lactose E00099 6134 Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate E00208 11177 lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent